Copyright © IMARC Service Pvt Ltd. All Rights Reserved Global Autoinjector Market Research and Forecast Report 2022-2027 Author: Elena Anderson, Marketing Manager | IMARC Group© 2019 IMARC All Rights Reserved
The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
About IMARC Group
Report Description
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Autoinjector Market Research Report:
Report Description Report Description and Highlights
According to the latest report by IMARC Group, titled “ Autoinjector Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-20 27 ” the global autoinjector market reached a strong growth in 2021. Autoinjectors refer to self-injectable medical devices used to administer drugs and antidotes through the subcutaneous or intramuscular route. They comprise spring-loaded prefilled syringes or cartridges that deliver a calculated dose of medication upon being activated. They facilitate easy selfadministration, enhance patient compliance, lower anxiety, and ensure dosage accuracy. They also help reduce needle phobia of patients, minimize needlestick injuries caused by hidden needles, and improve the efficiency of healthcare professionals. As a result, autoinjectors are widely utilized for rapid and safe drug administration during emergency conditions, including diabetes, multiple sclerosis (MS), migraine, seizures, psoriasis, and rheumatoid arthritis.
Request Free Sample Report: https://www.imarcgroup.com/autoinjector-market/requestsample
Global Autoinjector Market Trends :
The global autoinjector market is primarily driven by the increasing incidences of chronic and lifestyle diseases and the escalating demand for enhanced patient convenience. Additionally, individuals are rapidly shifting from conventional devices toward self-administrating devices, such as autoinjectors, due to the growing awareness regarding their benefits. In line with this, several favorable initiatives undertaken by governments of various countries to promote the usage of autoinjectors in schools for first-aid treatment during emergencies have augmented the product demand. Furthermore, the leading players are launching innovative, simple, and cost-effective autoinjectors based on advanced technologies for treating relapsing-remitting MS and other conditions, thereby propelling the market growth. Other factors, including the expanding healthcare industry, aging population, rising product approvals, surging adoption of targeted therapies, growing inclination toward homecare therapeutics, and ongoing research and development (R&D) activities, are also anticipated to drive the market further. Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
Report Description Report Description and Highlights
Report Description Report Description and Highlights Market ••••••BreakupSummary:byType:DisposableAutoinjectorsReusableAutoinjectorsBreakupbyApplication:RheumatoidArthritisAnaphylaxisMultipleSclerosisOthersBreakupbyEndUser:
Report Description Report Description and Highlights • Home Care Settings • Hospitals and Clinics Breakup by Region: • North America • United States • Canada • Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe•Germany•France•UnitedKingdom
Report Description Report Description and Highlights • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Competitive Landscape with Key Players: Antares Pharma Inc. Becton Dickinson and Company Bristol-Myers Squibb Company Eisai Co. Ltd. Eli Lilly and HaselmeierCompanyGmbH(Sulzer Ltd.) Johnson & Johnson Mylan N.V. (Viatris Inc.) Novartis AG SHL Medical AG Teva Pharmaceutical Industries Ltd. • Ypsomed Holding AG. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/autoinjector-market Report Description Report Description and Highlights
A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients
A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients
Report Description Report Description and Highlights © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
FOR MORE DETAILS Visit us at : Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com https://www.imarcgroup.com Contact Us
